W. D. STROUD, F.A.C.P.; A. E. LIVINGSTON; A. W. BROMER; J. B. VANDERVEER; G. C. GRIFFITH
Those who have assayed digitalis by any of the recognized biological methods are well aware of the difficulties encountered, and those who prescribe assayed products are frequently confronted with uncertain results. Consequently, any stable digitalis preparation producing the desired therapeutic effects and at the same time being sufficiently uniform in its action not to require a biological assay, would be greatly appreciated. From the long list of digitalis preparations on the market it is evident that no such ideal substance is available at the present time.
According to many reports, verodigen has been used in Europe for a number
STROUD WD, LIVINGSTON AE, BROMER AW, VANDERVEER JB, GRIFFITH GC. THE USE OF VERODIGEN (A DIGITALIS GLUCOSIDE) IN CARDIOVASCULAR DISEASE, ITS BIOLOGICAL ASSAY, AND PHARMACOLOGICAL ACTION1. Ann Intern Med. 1934;8:710–726. doi: 10.7326/0003-4819-8-6-710
Download citation file:
Published: Ann Intern Med. 1934;8(6):710-726.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use